Should I buy Omega Healthcare Investors (OHI) stock or is it too late?

Omega Healthcare Investors · Real Estate · price $45

See the full Omega Healthcare Investors (OHI) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Cantor Fitzgerald — 62% of its targets hit on this sector (13 calls tested). It aims for $56 (+24 %), call made on August 1, 2026, maturing on August 1, 2027 (74 d ago).

The 2 reliable analysts $51+13 %

The 7 other firms $48+6.1 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $51 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Omega Healthcare Investors

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	80 %	+10.1 %	10	$48 +6%
B of A Securities	50 %	-7.5 %	6	$46 +2%
Raymond James	53 %	+7.4 %	15	—

In short — Should you invest in Omega Healthcare Investors? Is it too late, still worth it? Analysts are split (33% buy, median target $48, i.e. +6%), and the most reliable on OHI targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on OHI, Mizuho (100% hit rate, 2 scored calls), targets $46 (call made on August 31, 2026, maturing on August 31, 2027) (+2%) in its most recent call.
Pays a dividend (5.6% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 5 are neutral and 1 is a sell.
Limited upside: the median target is only +6% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on OHI

Median target $48 (+6%) · 9 ratings · Hold consensus

Strong Buy00%

Buy333%

Hold556%

Sell111%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Omega Healthcare Investors now?

We won't decide for you. The facts: 33% of analysts rate it a buy, median target $48 (+6%), and Mizuho (most reliable on OHI, 100%) targets $46. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Omega Healthcare Investors?

Not according to analysts: the median target ($48) is still +6% above the current price ($45) (most reliable on OHI: Mizuho, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Omega Healthcare Investors still worth investing in?

It depends on the gap between the price ($45) and its estimated value: analysts target $48 on median (+6%), with 33% buys (most reliable on OHI: Mizuho, 100%). Cross-check with their real reliability on OHI and the cautions above. Information, not advice.

What's the main risk in buying OHI?

The consensus is not unanimous: of 9 ratings, 5 are neutral and 1 is a sell.

→ Go deeper: the full Omega Healthcare Investors profile (consensus, analyst reliability, price target, performance).